Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15,650 INR | -0.06% | -0.19% | -9.81% |
May. 01 | Procter & Gamble Hygiene Posts Decline in Fiscal Q4 Net Profit | MT |
Apr. 30 | Procter & Gamble Hygiene & Health Care's Net Profit Slips in Fiscal Q4 | MT |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.81% | 6.09B | C | ||
+14.40% | 396B | C- | ||
+13.58% | 142B | B- | ||
+18.09% | 77.56B | A+ | ||
-12.91% | 65.94B | A- | ||
-4.92% | 43.2B | - | ||
+6.63% | 35.03B | B- | ||
+11.64% | 18.17B | A- | ||
+14.49% | 15.96B | B | ||
-3.84% | 11.51B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
- Stock Market
- Equities
- PGHH Stock
- Ratings Procter & Gamble Hygiene and Health Care Limited